The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

A basic review of the anatomy, physiology and personal protective equipment related to the respiratory system.

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of ...

Smoking is a significant public health issue worldwide, despite the well-known warning labels on tobacco products. The message “smoking may be hazardous to health” is clear, yet many individuals ...

Objective To conduct a systematic review investigating the normal age-related changes in lung function in adults without known lung disease. Design Systematic review. Data sources MEDLINE, Embase and ...

In interstitial lung disease (ILD), quantitative computed tomography (qCT) is effective for prognosticating and for disease monitoring.

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

At 12 weeks, patients treated with ENV-101 showed statistically significant increases in lung volume compared with those ...

Shyamali Dharmage grew up in rural Sri Lanka and was inspired to become a doctor after watching the impact of the local ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...